Concomitant use of nesiritide and milrinone in decompensated congestive heart failure.
Smull
David L
DL
Division of Circulatory Physiology, Department of Medicine, Columbia Presbyterian Medical Center, New York, NY, USA. dsmull@triad.rr.com
Jorde
Ulrich P
UP
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D020105:Milrinone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D045283:Natriuretic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D020097:Natriuretic Peptide, Brain / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D011669:Pulmonary Wedge Pressure / Q000187:drug effects
D002316:Cardiotonic Agents; D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain; D020105:Milrinone